Dr. Bosserman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1100 San Bernardino Road Suite 1100
Upland, CA 91786Phone+1 909-949-2242Fax+1 909-981-5783- Is this information wrong?
Summary
- Dr. Linda Bosserman is a medical oncologist and Clinical Professor at City of Hope National Medical Center. She focuses on personalized precision medicine to empower networked cancer specialists to deliver value based cancer care both for patients seeing City of Hope specialists as well as patients throughout the county and internationally via telemedicine and remote second opinion services. She received her medical degree from Stanford University School of Medicine and oncology specialty training at Harvard's Dana Farber Cancer Institute. She has been in oncology practice for 32 years. She specializes in all aspects of breast cancer consultation and care while coordinating multidisciplinary consultations for patients with other cancer and blood malignancies with her remarkably talented colleagues at the City of Hope Duarte campus and its 31 networked cancer practices located throughout the 5 largest counties of California. She brings years of bed side experience to practical implementation methodologies to ensure the latest diagnostics and most effective therapies can be offered to patients in coordination with their treating physicians wherever they live. As Editor in Chief of ASCO's JCO-Oncology Practice journal, she reviews and interacts with clinical researchers and cancer practitioners on the latest care delivery, practice management and quality improvement science provided with key clinical and care delivery reviews and policy updates for busy practicing clinicians, administrators, policy makers and payers.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1985 - 1988
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1981 - 1984
- Stanford University School of MedicineClass of 1981
- University of California, BerkeleyA.B., Biochemistry, with Highest Honors, 1977
Certifications & Licensure
- CA State Medical License 1982 - 2026
- MA State Medical License 1985 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Best Doctors in America and Best Doctors in Breast Cancer (top 4% as voted by peers annually) Best Doctors in America
- Fellow American Society of Clinical Oncology, 2017
- Top Doctors:LA Area Castle Connolly, 2013
- Join now to see all
Clinical Trials
- Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2009 Apr 01
- Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer Start of enrollment: 2009 Sep 01
Publications & Presentations
PubMed
- 4 citationsPyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans.Linda D Bosserman, Isa Mambetsariev, Colton Ladbury, Afsaneh Barzi, Deron Johnson, Denise Morse, Debbie Deaville, Wade Smith, Swapnil Rajurkar, Amartej Merla, George H...> ;Journal of Clinical Medicine. 2022 Nov 14
- 4 citationsGenomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer.Jin Sun Lee, Susan E Yost, Sierra Min Li, Yujie Cui, Paul H Frankel, Yate-Ching Yuan, Daniel Schmolze, Colt A Egelston, Weihua Guo, Mireya Murga, Helen Chang, Linda Bo...> ;Cancers. 2022 Jun 28
- 12 citationsProspective Comparison of Medical Oncologists and a Machine Learning Model to Predict 3-Month Mortality in Patients With Metastatic Solid Tumors.Finly J Zachariah, Lorenzo A Rossi, Laura M Roberts, Linda D Bosserman> ;JAMA Network Open. 2022 May 2
- Join now to see all
Journal Articles
- Value-based Medicine and Integration of Tumor BiologyBrooks GA, Bosserman LD, Mambetsariev I, Salgia R, Am Soc Clin Oncol Educ Book, 1/1/2017
- American Society of Clinical Oncology Criteria for High-Quality Clinical Pathways in OncologyRobin T. Zon, Stephen B. Edge, Ray D. Page, James N. Frame, Gary H. Lyman, James L. Omel, Dana S. Wollins, Sybil R. Green, and Linda D. Bosserman, Journal of Oncology Practice, 1/1/2017
- Letter from the Editor: Clinical, practice, and policy trends: a round-up and review of the 2016 oncology landscapeBosserman LD, Journal of Community and Supportive Oncology, 1/1/2016
- Join now to see all
Abstracts/Posters
- Efficacy and Safety of Ixabepilone + Capecitabine in Elderly Patients with Anthracycline and Taxane Pretreated Metastatic Breast Cancer.Vahdat L,1 Vrodljak E,2 Gomez H,3 Li RK,4 ThomasE,5 Bosserman L,6 Sparano JA,7 Baselga J,8 Mukhopadhyaya P,9 Valero A10. 1Weill Cornell Medical College, New York, NY;..., American Geriatrics Society Annual Scientific Meeting, 1/1/2012
- Risk of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after adjuvant chemotherapy (CT) for early breast cancer (BC) in the community setting.Neelima Denduluri, Janet L. Esposito, Brian Turnwald, Yunfei Wang, Lina Asmar, J. Russell Hoverman, Marcus A. Neubaue, Linda D. Bosserman, Leslie T. Busby, Barry Don ..., J Clin Oncol; ASCO Breast Cancer Symposium, 1/1/2012
- A Randomized, Double-Blind, Placebo-Controlled Trials of Weekly Paclitaxel/Bevacizumab +/- Everolimus as First-Line Chemotherapy for Patients with HER2-Negative Metast...Denise A. Yardley MD1,2, Joyce O'Shaughnessy MD3, Linda Bosserman MD4, Anne Favret MD5, William Harwin MD6, Michael Juzur MD2, Susan Morgan MD6, Nancy Peacock MD2, Vic..., San Antonio Breast Cancer Symposium, 1/1/2011
- Join now to see all
Lectures
- American Society of Clinical Oncology (ASCO): 2012 Cancer Center Business SummitAmerican Society of Clinical Oncology(ASCO), Fort Worth, Texas - 10/11/2012
- Integrating Practice Guidelines and EMR into Community Oncology PracticeAlbuquerque, NM - 1/1/2008
- Implementing Clinical Guidelines in Community PracticeBrookfield, WI - 1/1/2008
- Join now to see all
Other
- American Journal of Managed Care. A Discussion on Oncology Quality Tools: Filling in the GapsBosserman L, Goldwater J, Malin J
http://www.ajmc.com/journals/evidence-based-oncology/2016/June-2016
1/1/2016 - Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and cor...Denise A. Yardley, MP Bates, J Weidler, L Bosserman, et. al., doi:10.1186/s13058-015-0543-x
1/1/2015 - VIDEO: Organizational Culture in the Oncology Medical Home: What Drives Success?Patt D, Bosserman L
http://www.medscape.org/viewarticle/837946
1/1/2015 - Join now to see all
Press Mentions
- New Journal of Oncology Practice Special Series Focuses on Real-World Approaches to Quality CareDecember 12th, 2018
- Charting New Horizons for Science ImmunologyApril 6th, 2018
- Don't Let Physician Burnout Threaten Your Practice's HealthApril 11th, 2017
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish
Hospital Affiliations
- Pomona Valley Hospital Medical CenterPomona, California
- San Antonio Regional HospitalUpland, California
- City of Hope Comprehensive Cancer CenterDuarte, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: